Jefferies Financial Group upgraded shares of Option Care Health (NASDAQ:OPCH - Free Report) from a hold rating to a buy rating in a report published on Thursday, Marketbeat reports. They currently have $35.00 target price on the stock, up from their prior target price of $26.00.
A number of other brokerages have also commented on OPCH. JMP Securities reaffirmed a "market outperform" rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Truist Financial reduced their price objective on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a report on Friday, November 1st. UBS Group started coverage on Option Care Health in a report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price for the company. Barrington Research increased their price target on Option Care Health from $32.00 to $33.00 and gave the stock an "outperform" rating in a research report on Tuesday, January 14th. Finally, Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $31.14.
View Our Latest Stock Analysis on OPCH
Option Care Health Trading Up 2.4 %
NASDAQ OPCH traded up $0.72 during trading on Thursday, hitting $30.03. The stock had a trading volume of 1,517,835 shares, compared to its average volume of 2,291,088. The stock has a market capitalization of $5.11 billion, a price-to-earnings ratio of 25.16, a P/E/G ratio of 2.12 and a beta of 1.31. The stock has a 50 day simple moving average of $24.10 and a 200 day simple moving average of $27.78. Option Care Health has a one year low of $21.39 and a one year high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.
Insider Buying and Selling at Option Care Health
In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.64% of the stock is owned by insiders.
Institutional Trading of Option Care Health
A number of institutional investors have recently bought and sold shares of the stock. Wellington Management Group LLP increased its holdings in shares of Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock valued at $310,650,000 after purchasing an additional 1,328,326 shares during the period. FMR LLC boosted its position in Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company's stock valued at $235,265,000 after buying an additional 4,304,896 shares during the last quarter. Westfield Capital Management Co. LP increased its holdings in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock worth $203,204,000 after buying an additional 599,589 shares during the period. State Street Corp raised its position in Option Care Health by 1.4% during the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company's stock worth $195,849,000 after buying an additional 83,395 shares during the last quarter. Finally, Thrivent Financial for Lutherans lifted its stake in Option Care Health by 7.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company's stock valued at $183,541,000 after acquiring an additional 404,811 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.
About Option Care Health
(
Get Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
